Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer
Shah, Manish A., Kang, Yoon-Koo, Thuss-Patience, Peter C., Ohtsu, Atsushi, Ajani, Jaffer A., Van Cutsem, Eric, Hoersch, Silke, Harle-Yge, Marie-Laurence, de Haas, Sanne Lysbet
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2019)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2019)
Get full text
Journal Article
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐positive advanced breast cancer
Kim, Sung‐Bae, Wildiers, Hans, Krop, Ian E., Smitt, Melanie, Yu, Ron, Lysbet de Haas, Sanne, Gonzalez‐Martin, Antonio
Published in International journal of cancer (15.11.2016)
Published in International journal of cancer (15.11.2016)
Get full text
Journal Article
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
Loibl, Sibylle, Huang, Chiun-Sheng, Mano, Max S, Mamounas, Eleftherios P, Geyer, Charles E, Untch, Michael, Thery, Jean-Christophe, Schwaner, Ingo, Limentani, Steven, Loman, Niklas, Lübbe, Kristina, Chang, Jenny C, Hatschek, Thomas, Tesarowski, David, Song, Chunyan, Lysbet de Haas, Sanne, Boulet, Thomas, Lambertini, Chiara, Wolmark, Norman
Published in NPJ breast cancer (19.09.2022)
Published in NPJ breast cancer (19.09.2022)
Get full text
Journal Article
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer
Perez, Edith A, de Haas, Sanne Lysbet, Eiermann, Wolfgang, Barrios, Carlos H, Toi, Masakazu, Im, Young-Hyuck, Conte, Pier Franco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier B, Burris, 3rd, Howard A, Stanzel, Sven, Patre, Monika, Ellis, Paul Anthony
Published in BMC cancer (30.05.2019)
Published in BMC cancer (30.05.2019)
Get full text
Journal Article
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial
Huang, Liang, Pang, Da, Yang, Hongjian, Li, Wei, Wang, Shusen, Cui, Shude, Liao, Ning, Wang, Yongsheng, Wang, Chuan, Chang, Yuan-Ching, Wang, Hwei-Chung, Kang, Seok Yun, Seo, Jae Hong, Shen, Kunwei, Laohawiriyakamol, Suphawat, Jiang, Zefei, Wang, Haiyan, Lamour, François, Song, Grace, Curran, Michelle, Duan, Chunzhe, Lysbet de Haas, Sanne, Restuccia, Eleonora, Shao, Zhimin
Published in Nature communications (09.03.2024)
Published in Nature communications (09.03.2024)
Get full text
Journal Article
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer
Harbeck, Nadia, von Schumann, Raquel, Kates, Ronald Ernest, Braun, Michael, Kuemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Malter, Wolfram, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, Grischke, Eva-Maria, Biehl, Claudia, Liedtke, Cornelia, De Haas, Sanne Lysbet, Deurloo, Regula, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Gluz, Oleg
Published in Cancers (29.09.2021)
Published in Cancers (29.09.2021)
Get full text
Journal Article
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
Dang, Chau, Ewer, Michael S, Delaloge, Suzette, Ferrero, Jean-Marc, Colomer, Ramon, de la Cruz-Merino, Luis, Werner, Theresa L, Dadswell, Katherine, Verrill, Mark, Eiger, Daniel, Sarkar, Sriparna, de Haas, Sanne Lysbet, Restuccia, Eleonora, Swain, Sandra M
Published in Cancers (24.05.2022)
Published in Cancers (24.05.2022)
Get full text
Journal Article
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer
Perez, Edith A, de Haas, Sanne Lysbet, Eiermann, Wolfgang, Barrios, Carlos H, Toi, Masakazu, Im, Young-Hyuck, Conte, Pier Franco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier B, Burris, 3rd, Howard A, Stanzel, Sven, Patre, Monika, Ellis, Paul Anthony
Published in BMC cancer (24.06.2019)
Published in BMC cancer (24.06.2019)
Get full text
Journal Article
Abstract PD5-11: Association of immune gene expression with outcome in the MARIANNE phase 3 clinical trial in HER2-positive metastatic breast cancer (MBC)
Perez, Edith A, de Haas, Sanne Lysbet, Barrios, Carlos H, Eiermann, Wolfgang, Toi, Masakazu, Im, Young-Hyuck, Conte, Pier Franco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier B, Burris, Howard A, Lambertini, Chiara, Hoersch, Silke, Patre, Monika, Ellis, Paul Anthony
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract P2-11-07: Association of PIK3CA mutations with efficacy in HER2-positive first-line metastatic breast cancer: a meta-analysis
Swain, Sandra, Cortés, Javier, Xu, Binghe, Lambertini, Chiara, Essioux, Laurent, Knott, Adam, Restuccia, Eleonora, Madjar, Katrin, De Haas, Sanne Lysbet
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PO2-11-06: Anti-Müllerian hormone in Young women with breast CAncer to predict permanent loss of ovarian function after chemotherapy and anti-HER2 therapy (AMYCA): a biomarker analysis of the BETH and KAITLIN trials
Lambertini, Matteo, Allegranza, Deirdre, Laubender, Ruediger, Harbeck, Nadia, Swain, Sandra, Geyer, Charles, Slamon, Dennis, Bobba, Gabriella, Lambertini, Chiara, De Haas, Sanne Lysbet, Restuccia, Eleonora, Luis, Ines Vaz, Cameron, David, Krop, Ian, Winer, Eric, Anderson, Richard
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
RESPONSIVENESS TO ANGIOGENESIS INHIBITORS
Scherer Stefan, de Haas Sanne Lysbet, Lambrechts Diether, Carmeliet Peter
Year of Publication 09.03.2017
Get full text
Year of Publication 09.03.2017
Patent
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER
DE HAAS, Sanne Lysbet, KLAUSE, Ursula, DELMAR, Paul, SCHERER, Stefan, FOERNZLER, Dorothee
Year of Publication 19.04.2017
Get full text
Year of Publication 19.04.2017
Patent
método de determinação da susceptibilidade de pacientes ao desenvolvimento da hipertensão, composição farmacêutica, kit de condução, método de redução e método de tratamento de pacientes
PAUL DELMAR, DIETHER LAMBRECHTS, STEFAN SCHERER, SANNE LYSBET DE HAAS
Year of Publication 21.03.2017
Get full text
Year of Publication 21.03.2017
Patent
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER
DE HAAS, Sanne Lysbet, KLAUSE, Ursula, DELMAR, Paul, SCHERER, Stefan, FOERNZLER, Dorothee
Year of Publication 18.01.2017
Get full text
Year of Publication 18.01.2017
Patent
Responsiveness to Angiogenesis Inhibitors
SCHERER, STEFAN, DE HAAS, SANNE LYSBET, LAMBRECHTS, DIETHER, DELMAR, PAUL
Year of Publication 28.10.2016
Get full text
Year of Publication 28.10.2016
Patent
Method for predicting risk of hypertension associated with anti-angiogenesis therapy
DE HAAS SANNE LYSBET, LAMBRECHTS DIETHER, SCHERER STEFAN, DELMAR PAUL
Year of Publication 28.10.2016
Get full text
Year of Publication 28.10.2016
Patent
METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY
SCHERER, STEFAN, DE HAAS, SANNE LYSBET, LAMBRECHTS, DIETHER, DELMAR, PAUL
Year of Publication 26.10.2016
Get full text
Year of Publication 26.10.2016
Patent
Responsiveness to angiogenesis inhibitors
DE HAAS SANNE LYSBET, CARMELIET PETER, LAMBRECHTS DIETHER, SCHERER STEFAN
Year of Publication 29.07.2016
Get full text
Year of Publication 29.07.2016
Patent